Unrealized Gains and Operating Results Lift Berkshire
We expect to raise our fair value estimate following a stronger conclusion to the company's fiscal year than we had been projecting.
We expect to raise our fair value estimate for wide-moat-rated Berkshire Hathaway (BRK.B) (in the neighborhood of 5%-10%) following a stronger conclusion to the company's fiscal year than we had been projecting. Fourth-quarter (full-year) revenue, which includes unrealized and realized gains/losses from Berkshire's investments and derivatives portfolios, increased 7.3% (declined 12.5%) year over year to $103.7 billion ($286.3 billion). Excluding the impact of investment and derivative gains/losses and other adjustments, fourth-quarter (full-year) operating revenue declined 1.3% (3.4%) to $64.4 billion ($245.4 billion). Operating earnings, exclusive of the impact of investment and derivative gains/losses but including goodwill and intangible asset impairments (including $9.8 billion attributable to Berkshire's 2016 acquisition of Precision Castparts), increased 13.6% (declined 8.6%) year over year to $5.0 billion ($21.9 billion) during the December quarter (full year). When including the impact of the investment and derivative gains/losses, net earnings increased 23.8% (fell 47.6%) to $35.8 billion ($42.5 billion).
Berkshire closed out the December quarter with $138.3 billion in cash, down from a record $146.6 billion at the end of June 2020, with Berkshire (by our estimates) having around $120 billion in dry powder that could be committed to investments, acquisitions, and share repurchases in the first quarter of 2021. The firm repurchased $8.8 billion worth of its common stock during the fourth quarter, bringing full-year share repurchases up to $24.7 billion (which eliminated around 5% of the company's shares outstanding last year). While we expect Berkshire to continue to buy back shares, we're not sure that the firm will be buying back $9 billion a quarter (as it did during the back half of 2020) but with cash continuing to build up on the balance sheet, share repurchases may end up being the company's best capital allocation outlet.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Greggory Warren does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.